These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1575262)

  • 1. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.
    Lydiard RB; Ballenger JC; Laraia MT; Fossey MD; Beinfeld MC
    Am J Psychiatry; 1992 May; 149(5):691-3. PubMed ID: 1575262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin and panic disorder--three unsettled questions.
    Rehfeld JF
    Regul Pept; 2000 Sep; 93(1-3):79-83. PubMed ID: 11033055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system.
    Flint A; Bradwejn J; Vaccarino F; Gutkowska J; Palmour R; Koszycki D
    Neuropsychopharmacology; 2002 Oct; 27(4):663-71. PubMed ID: 12377403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia.
    Akiyoshi J; Isogawa K; Tsutsumi T; Kasturagi S; Kohno K; Furuta M; Yamamoto Y; Yamada K; Fujii I
    Biol Psychiatry; 1997 Jul; 42(2):151-4. PubMed ID: 9209734
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholecystokinin hypothesis of anxiety and panic disorder.
    Bradwejn J; Koszycki D
    Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic.
    Sánchez-Fernández C; González C; Mercer LD; Beart PM; Ruiz-Gayo M; Fernández-Alfonso MS
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):364-70. PubMed ID: 12621311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiological investigations into the role of cholecystokinin in panic disorder.
    Bradwejn J
    J Psychiatry Neurosci; 1993 Jul; 18(4):178-88. PubMed ID: 8104032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder.
    Akiyoshi J; Moriyama T; Isogawa K; Miyamoto M; Sasaki I; Kuga K; Yamamoto H; Yamada K; Fujii I
    J Neurochem; 1996 Apr; 66(4):1610-6. PubMed ID: 8627317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the significance of cholecystokinin receptors in panic disorder.
    van Megen HJ; den Boer JA; Westenberg HG
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1235-46. PubMed ID: 7863014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.
    Kato T; Wang ZW; Zoega T; Crowe RR
    Am J Med Genet; 1996 Jul; 67(4):401-5. PubMed ID: 8837709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin peptides and receptor binding in Alzheimer's disease.
    Löfberg C; Harro J; Gottfries CG; Oreland L
    J Neural Transm (Vienna); 1996; 103(7):851-60. PubMed ID: 8872869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte cholecystokinin concentrations in panic disorder.
    Brambilla F; Bellodi L; Perna G; Garberi A; Panerai A; Sacerdote P
    Am J Psychiatry; 1993 Jul; 150(7):1111-3. PubMed ID: 8317587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A; Holsboer F; Rupprecht R
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA; Slaap B; van Es-Radhakishun F; Pande AC
    Psychopharmacology (Berl); 1997 Feb; 129(3):243-8. PubMed ID: 9084062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
    Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
    J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is cholecystokinin a biological support in panic attacks?].
    Bourin M; Bradwejn J; Koszycki D
    Encephale; 1991; 17(5):475-9. PubMed ID: 1686250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D; Torres S; Swain JE; Bradwejn J
    Psychosom Med; 2005; 67(4):590-5. PubMed ID: 16046372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.
    Bradwejn J; Koszycki D
    Am J Psychiatry; 1994 Feb; 151(2):261-3. PubMed ID: 8296900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.